187 related articles for article (PubMed ID: 37809682)
1. Single-cell data analysis of malignant epithelial cell heterogeneity in lung adenocarcinoma for patient classification and prognosis prediction.
Ran X; Tong L; Chenghao W; Qi L; Bo P; Jiaying Z; Jun W; Linyou Z
Heliyon; 2023 Sep; 9(9):e20164. PubMed ID: 37809682
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma.
Mao S; Wang Y; Chao N; Zeng L; Zhang L
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38616208
[TBL] [Abstract][Full Text] [Related]
3. Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma.
Fan T; Lu J; Niu D; Zhang Y; Wang B; Zhang B; Zhang Z; He X; Peng N; Li B; Fang H; Gong Z; Zhang L
Front Immunol; 2022; 13():1046121. PubMed ID: 36483553
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing.
Wang H; Han G; Chen J
Aging (Albany NY); 2023 Jun; 15(12):5339-5354. PubMed ID: 37335089
[TBL] [Abstract][Full Text] [Related]
5. Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.
Zhang P; Liu J; Pei S; Wu D; Xie J; Liu J; Li J
Front Immunol; 2023; 14():1189520. PubMed ID: 37256127
[TBL] [Abstract][Full Text] [Related]
6. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
7. Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma.
Lu T; Xu R; Wang C; Zhou X; Parra-Medina R; Díaz-Peña R; Peng B; Zhang L
J Thorac Dis; 2023 Jul; 15(7):3885-3907. PubMed ID: 37559628
[TBL] [Abstract][Full Text] [Related]
8. Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing.
Chen M; Li H; Xu X; Bao X; Xue L; Ai X; Xu J; Xu M; Shi Y; Zhen T; Li J; Yang Y; Ji Y; Fu Z; Xing K; Qing T; Wang Q; Zhong P; Zhu S
Cell Death Dis; 2023 May; 14(5):330. PubMed ID: 37202394
[TBL] [Abstract][Full Text] [Related]
9. Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor.
Wang X; Zhang D; Guan X; Ma S; Zhou W; Peng J; Yuan L; Wang Y; Jin S; Xu Q; Li D; Wu S; Jia G; Zhang C; Jia W
Transl Lung Cancer Res; 2023 Mar; 12(3):547-565. PubMed ID: 37057123
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
[TBL] [Abstract][Full Text] [Related]
11. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
Wu X; Wang S; Chen K
Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
[TBL] [Abstract][Full Text] [Related]
12. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.
Huang R; Wang X; Yin X; Zhou Y; Sun J; Yin Z; Zhu Z
Front Genet; 2022; 13():976990. PubMed ID: 36338972
[No Abstract] [Full Text] [Related]
13. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
He J; Zhang W; Li F; Yu Y
Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed genes in lung adenocarcinoma cells using single-cell RNA sequencing not detected using traditional RNA sequencing and microarray.
Chen Z; Zhao M; Li M; Sui Q; Bian Y; Liang J; Hu Z; Zheng Y; Lu T; Huang Y; Zhan C; Jiang W; Wang Q; Tan L
Lab Invest; 2020 Oct; 100(10):1318-1329. PubMed ID: 32327726
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
Shu J; Jiang J; Zhao G
Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
17. Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Chen Z; Yang X; Bi G; Liang J; Hu Z; Zhao M; Li M; Lu T; Zheng Y; Sui Q; Yang Y; Zhan C; Jiang W; Wang Q; Tan L
Int J Biol Sci; 2020; 16(12):2205-2219. PubMed ID: 32549766
[No Abstract] [Full Text] [Related]
18. Development and validation of a gene-based classification model for pN2 lung adenocarcinoma.
Zhu J; Wang W; Ma Y; Zhao J; Xiong Y
Transl Lung Cancer Res; 2023 Mar; 12(3):494-509. PubMed ID: 37057107
[TBL] [Abstract][Full Text] [Related]
19. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma.
Zhang P; Pei S; Gong Z; Feng Y; Zhang X; Yang F; Wang W
Front Immunol; 2023; 14():1115272. PubMed ID: 36776843
[TBL] [Abstract][Full Text] [Related]
20. Metabolic heterogeneity in early-stage lung adenocarcinoma revealed by RNA-seq and scRNA-seq.
Zhang Y; Shi J; Luo J; Liu C; Zhu L
Clin Transl Oncol; 2023 Jun; 25(6):1844-1855. PubMed ID: 36692643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
